ANDA 207309, held by Flamingo Pharmaceuticals. Metronidazole.
As of Nov 21, 2026, ANDA 207309 (Metronidazole), held by Flamingo Pharmaceuticals, was first approved by FDA on May 16, 2016, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| May 16, 2016 | Original application | Approved | None posted |
| Metronidazole250MG · tablet;oral | Metronidazole | Discontinued |
| Metronidazole500MG · tablet;oral | Metronidazole | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters